The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

INTERVENTIONS FOR HYPERTENSION AND STROKE

Intravenous ultrasound-guided balloon pulmonary angioplasty in the treatment of totally occluded chronic thromboembolic pulmonary hypertension

EuroIntervention 2018;14:234-235 published online October 2017. DOI: 10.4244/EIJ-D-17-00770a

Division of Cardiology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Balloon pulmonary angioplasty (BPA) is efficacious in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH)1,2. Lesions of CTEPH are categorised by their characteristic appearance on pulmonary angiography3. While there are studies using intravascular ultrasound (IVUS)-guided BPA for inoperable CTEPH1, there are currently no established procedures specifically for chronic totally occluded (CTO) lesions.

The patient was a 66-year-old female. Pulmonary artery angiography with a Profit 6 Fr JL4 guide catheter (Goodman, Aichi, Japan), anteroposterior straight view, showed CTO of the left inferior lingual artery (Panel A). A 190 cm guidewire (Chevalier® 14 tapered 30; Cordis, Cardinal Health, Tokyo, Japan) was advanced slightly into the organised thrombus while guiding with IVUS using an Eagle Eye® Platinum ST catheter (Philips, Amsterdam, the Netherlands) along the guidewire. We confirmed the location of the IVUS catheter within the organised thrombus (Panel B2, image of position on Panel B1) and continued to advance it while maintaining the position of the guidewire (Moving image 1, Moving image 2).

When the location of the IVUS catheter in the true lumen of the vessel was confirmed, it was further advanced through the CTO into the distal true lumen (Panel B3, image of position on Panel B1). The lesion was then dilated with a 4 mm balloon catheter. With the preceding technique using IVUS, we could complete the BPA of the CTO (Panel C). No side effects were noted with this procedure.

The spherical tip of the IVUS catheter and the imaging distance of the tip of only 2.5 mm allowed the identification and advancement of the IVUS catheter through the true vessel. The risk of perforating the pulmonary artery is low using this technique. We could also reach the true lumen using this procedure despite poor peripheral blood flow immediately after the BPA. However, since the thickness of the layer of organised thrombus is unique to each lesion, the IVUS catheter may not pass through some lesions where the thrombus is too thick. The rigidity of the Eagle Eye catheter might also preclude its use in severely tortuous vessels, but its use in straight vessels makes it more suitable. The guidewire requires a certain degree of stiffness to support the IVUS catheter.

The authors have performed five cases using this procedure with a success rate of 80% and no significant morbidity or mortality. With careful patient selection, IVUS-guided BPA can serve as an alternative treatment of choice in approaching lesions with CTO in patients with CTEPH.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Preceding IVUS into the CTO lesion.

Moving image 2. IVUS image during the procedure.

  • Moving image 1. Preceding IVUS into the CTO lesion.
  • Moving image 2. IVUS image during the procedure.

Read next article

Percutaneous extraction of a leadless Micra pacemaker from the pulmonary artery in a patient with complex congenital heart disease and complete heart block